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Background:  Most  studies  of  chronic  postoperative  pain  focussed  on  major  surgical  procedures.  Chronic
postoperative  pain  occurred  in  10%  to 50%  of patients  and  exhibited  neuropathic  features  in 5% to  68%  of
cases.  The  objectives  of this  prospective  single-centre  study  were  to determine  the rates  of occurrence  and
associated  factors  of  any  chronic  pain  and  of  neuropathic  chronic  pain  1 year  after  orthopaedic  surgery
on  the  foot.
Methods: We  included  consecutive  patients  who  underwent  scheduled  orthopaedic  surgery  on  the foot  or
ankle at a university  hospital  centre  between  2009  and  2011.  All  patients  received  a  multimodal  analgesia
regimen  that  usually  combined  a continuous  popliteal  sciatic  nerve  block,  paracetamol,  and  ketoprofen,
with  additional  ketamine  if deemed  appropriate.  A telephone  interview  was conducted  1 year  after  the
surgical procedure.  The  main  outcome  measures  were  moderate-to-severe  pain  (numerical  rating  scale
score >  3/10)  1 year  after  surgery  at  rest  and  during  walking,  and  presence  of  neuropathic  pain  (deﬁned
using  the  DN2  score).  Multivariate  analysis  was  performed  to look  for associations  of various  perioperative
clinical  variables  with  pain.
Results:  One year  after  surgery,  55  of  260 (21%)  patients  reported  moderate-to-severe  pain at  rest,  111
(43%) moderate-to-severe  pain  during  walking,  and  9 (3%) neuropathic  pain.  By multivariate  analysis,
factors  independently  associated  with  moderate-to-severe  pain  at rest  and/or  during  walking  1  year
after  surgery  were  moderate-to-severe  pain  during  the  ﬁrst postoperative  night (P = 0.048)  and/or  day
(P  =  0.043)  and  revision  surgery  (P =  0.001).
Discussion:  The  rate of  occurrence  of  moderate-to-severe  pain  1  year  after  orthopaedic  foot  surgery  is
similar  to  that seen  after  major  surgical  procedures,  whereas  neuropathic  pain  seems  rare.  Orthopaedic
surgery  on  the  ankle  or hindfoot  is not  more  likely  to  be followed  by  chronic  pain  compared  to surgery
for  hallux  valgus  or  toe  abnormalities.  There  is  some  evidence  that  earlier  surgery  might  be beneﬁcial.
Level  of evidence:  IV,  prospective  observational  longitudinal  cohort  study.
©  2014  Published  by Elsevier  Masson  SAS.. Introduction
In 20% of patients referred to specialised centres for chronic
ain, surgery is the main aetiological factor. Chronic postsurgi-
al pain (CPSP) is deﬁned as postoperative pain occurring in the
bsence of an identiﬁable cause (local complication) and persist-
ng for more than 2 months (the time needed for normal healing to
ccur) [1]. Most studies of CPSP focussed on major procedures (e.g.,
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877-0568/© 2014 Published by Elsevier Masson SAS.thoracotomy and mastectomy) and showed rates of occurrence
ranging from 10% to 50% [2,3], with neuropathic features in two-
thirds of cases [4]. CPSP often occurs in patients with a history of
chronic preoperative pain. Thus, in clinical practice, patients with
pain before surgery often continue to report pain after surgery.
In orthopaedic practice, surgery is performed to relieve pain.
This fact complicates the assessment of pain persisting after
surgery. For instance, 1 year after carpal tunnel surgery, 36% of
patients reported pain in the wrist and/or hand on the operated
side; pain different from the preoperative pain was  reported by
22% of patients and pain similar to the preoperative pain by 12%
of patients [5]. In studies of total hip or knee arthroplasty, 28%
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fter the procedure [6,7]. In another study, 27% and 44% of patients
omplained of pain 3 to 4 years after total hip or knee arthro-
lasty, respectively, [8] and the pain exhibited neuropathic features
n 1% and 6% of patients, respectively [8]. The amount of periop-
rative data collected in these studies was usually limited, most
otably regarding the analgesia regimen. This point is important
ince speciﬁc postoperative analgesic regimens have been proven
o decrease the frequency of chronic pain after total hip arthro-
lasty [9] or of neuropathic pain after total knee arthroplasty [10].
o published data are available on the rate of occurrence of chronic
nd/or neuropathic pain after orthopaedic surgical procedures on
he foot. Studies of these procedures usually focussed on functional
cores to describe outcomes [11–13].
Here, our objectives were to determine the rate of occurrence
nd associated factors of chronic pain and neuropathic pain 1 year
fter orthopaedic surgery on the foot.
. Methods
.1. Inclusion criteria
We  conducted a prospective observational study of patients
anaged at a single university centre between October 2009 and
ugust 2011. The study did not lead to any changes in standard care
nd ethics committee approval was consequently not required by
rench legislation. We  nevertheless obtained oral informed con-
ent from all patients during the telephone interview 1 year after
urgery.
We  included patients who met  the two following criteria:
urgery involving the hallux and/or lesser toes (phalanges and/or
etatarsals), Lisfranc joint, Chopart joint, or ankle; and postopera-
ive analgesia regimen comprising a popliteal perineural catheter
r long-duration popliteal nerve block (with ropivacaine). Non-
nclusion criteria were surgery that did not involve the bones of the
oot and surgery involving the bones of a single lesser toe. Exclusion
riteria were harvesting of an iliac bone graft, other concomitant
urgical procedure, trauma within the past 15 days, sepsis, patient
nable to self-evaluate pain intensity on a simple numerical rating
cale (NRS, from 0, no pain; to 10, worst pain imaginable), severely
mpaired sensory function, and refusal to participate in the study.
.2. Anaesthesia and analgesia
The anaesthesia and analgesia techniques were chosen during
he pre-anaesthesia visit based on the patient’s medical history
nd wishes. Regional anaesthesia was suggested as the ﬁrst-line
ethod if the surgeon predicted that the procedure would last less
han 90 minutes. Pre-medication included 0.25 to 0.5 mg  of alprazo-
am. In the operating room, the patient’s vital signs were monitored
on-invasively.
Continuous regional analgesia was offered routinely and
onsisted in a continuous popliteal sciatic nerve block. The nerve
as identiﬁed by stimulation [14] or, starting in October 2010, by
ltrasonography with insertion of the needle within the ultrasound
eld (4–13 MHz  12L-SC probe, Venue 40 ultrasound machine, Gen-
ral Electric Healthcare, Vélizy, France). The needle was then used
o inject 20 mL  of 0.475% ropivacaine or 2% mepivacaine/0.75%
opivacaine. A non-stimulating catheter (Plexolong 20G, Pajunk,
eisingen, Germany) was introduced 3–5 cm beyond the needle
ip then secured to the skin using adhesive tape.General anaesthesia was induced intravenously (sufentanil
.2–0.3 g/kg, propofol 2–3 mg/kg, atracurium 0.5 mg/kg, and
etamine 0.5 mg/kg) then maintained by inhalation of sevoﬂurane
nd nitrous oxide.: Surgery & Research 100 (2014) 767–773
Regional anaesthesia consisted of femoral and popliteal nerve
blocks (20 mL  of 2% mepivacaine/0.75% ropivacaine for each block).
If deemed necessary by the anaesthesiologist, intravenous sedation
could be administered (midazolam 1 mg  and sufentanil 5 g).
All anaesthetic and analgesic procedures were either performed
or directly supervised by 1 of 8 anaesthesiologists/intensivists with
more than 4 years of experience with orthopaedic surgery.
2.3. Surgical management
The lower-limb veins were emptied and a pneumatic tourniquet
was placed at the thigh and inﬂated to 300 mmHg. At the end of
the surgical procedure, a suction drain was  usually left in place.
All surgical procedures were performed or directly supervised by a
senior surgeon.
2.4. Postoperative care
In the post-anaesthesia care unit, intravenous morphine titra-
tion was  performed in patients with moderate-to-severe pain
(deﬁned as a NRS score > 3/10). Continuous regional analgesia com-
prised 0.2% ropivacaine (5 mL/h) via an electronic pump (AmbITTM,
Sorenson Medical, Salt Lake City, UT, USA) or an elastomeric pump
(Infusor LV5TM 300 mL,  Baxter, Deerﬁeld, MA,  USA). The pumps
were weighed and checked at regular intervals [14]. The catheter
was clamped on the morning of the second day then removed
6 hours later in the absence of moderate-to-severe pain.
The systemic postoperative analgesia regimen consisted of
paracetamol (4 g/d), ketoprofen for 48 h (200–300 mg/d) in the
absence of contra-indications (creatinine clearance < 30 mL/min,
history of gastro-duodenal ulcer, allergy, or asthma induced by
non-steroidal anti-inﬂammatory drugs). The use of ketamine
(2 g/kg/min for 24 h, maximum 250 mg/d) was at the discretion
of the anaesthesiologist [15].
Morphine was  prescribed as the rescue analgesic and adminis-
tered either via a patient-controlled intravenous pump (1 mg  bolus,
refractory period of 7 minutes, maximum dosage 20 mg over 4 h, no
continuous administration) or via the oral or subcutaneous route
on demand.
At discharge, each patient was given a prescription of paraceta-
mol  and an appointment for follow-up radiographs and a surgeon
visit 45 days later. At our institution, none of the surgical procedures
included in the study were performed on an outpatient basis.
2.5. Collection of clinical perioperative data
The characteristics of the patient, anaesthesia, surgical proce-
dure, and perioperative analgesia were entered in the patient’s
anaesthesia record and electronic medical record, as well as by our
institution’s electronic prescription software (Actipidos Nursepad
4.2.7, Medicares, Pessac, France).
2.6. Questionnaire used to evaluate chronic pain 1 year after
surgery
Each patient was  asked to participate in a telephone interview
1 year (± 3 months) after the surgical procedure. The interview
involved completing the questionnaire shown in Appendix 1.
Patients who  failed to answer three telephone calls were classiﬁed
as lost to follow-up. The questionnaire included a self-evaluation of
pain intensity using an NRS, identiﬁcation of the location of the pain
in the operated foot at rest and during walking, determination of
the DN2 score for neuropathic pain features [16], an assessment of
the impact of the pain (use of analgesics, difﬁculties with footwear,
need for walking aids, and global interference with daily life), and









































patients. Neuropathic pain was  reported by 9 (3%) patients.
The mean NRS scores were 1.7 ± 2.6 (range, 0–9) for pain at rest
and 3.0 ± 3.0 (range, 0–10) for pain during walking. Compared to
Fig. 1. Numbers of patients with and without pain at rest before and 1 year after
surgery. The numbers of patients are reported in the histograms and the proportions
of  patients on the Y-axis.F. Remérand et al. / Orthopaedics & Trauma
Patients with a clear recollection of their preoperative pain were
sked to complete the same questionnaire for the 2 weeks before
urgery and to assess the duration of the preoperative pain.
.7. Statistical analysis
The three main outcome measures were moderate-to-severe
ain at rest, moderate-to-severe pain during walking, and neuro-
athic pain (DN2 score ≥ 3, Appendix 2). These outcome measures
ere assessed 1 year after surgery.
Quantitative variables were described as mean ± SD and qual-
tative variables as number (%). Age and NRS pain scores were
onverted into qualitative variables (> vs. < 50 years of age and pres-
nce vs. absence of moderate-to-severe pain).
A univariate analysis was performed using the two-sided
isher’s test to compare qualitative variables. Variables yielding
 values < 0.15 by univariate analysis and available to clinicians
n the immediate preoperative and postoperative periods were
ntered into a multivariate model. Statistical analyses were per-
ormed using PASW Statistics 18 software (SPSS Inc., Chicago, IL,




During the study period, 436 patients underwent foot surgery
t our institution, including 382 who met  our inclusion crite-
ia. Organisational reasons prevented us from calling 85 of these
atients, 1 year after surgery. Of the 297 remaining patients, 37
ere lost to follow-up and none declined study participation. Thus,
60 (88%) of the 297 patients called for the 1-year interview were
ncluded in our analysis. Among them, 252 clearly recollected their
reoperative pain.
.2. Patient characteristics
Mean age of the 260 patients was 58 ± 14 years and mean body
ass index was 26 ± 5 kg/m2. There were 185 (71%) women.
Preoperatively, 165 (65%) patients had pain at rest and 233 (93%)
uring walking. The pain was moderate-to-severe at rest in 116
46%) patients and during walking in 218 (87%) patients. The mean
RS score was 3.8 ± 3.4 at rest and 6.6 ± 2.7 during walking. Preop-
rative neuropathic pain was reported by 12 (5%) patients.
The complications listed below were reported by 70 (30%)
atients:
complex regional pain syndrome type I (n = 16), with a fatigue
fracture in 1 patient;
infection/abscess (n = 12), requiring revision surgery in the oper-
ating room in 2 patients and outpatient drainage of an abscess in
1 patient (who subsequently experienced complex regional pain
syndrome type I);
skin complications (wound dehiscence or necrosis) (n = 7);
haematoma (n = 8) successfully managed without revision
surgery;
neurological complications (n = 5), including surgically managed
neuroma in 1 patient and sciatic neuropathy related to regional
analgesia;
mechanical complications (n = 16) consisting of non-union, dis-
comfort related to the material, material breakage, tendinitis,
fatigue fracture, and early recurrence of the symptoms or defor-
mities;
other mild complications (n = 17) consisting of delayed awaken-
ing, postoperative nausea and/or vomiting, persistent oedema,: Surgery & Research 100 (2014) 767–773 769
keloid scar, skin reaction to povidone-iodine, and scar perceived
as bothersome.
3.3. Rate of occurrence of pain at rest and during walking 1 year
after surgery
After 1 year, 95 (37%) patients reported pain at rest and 164
(63%) during walking (Figs. 1 and 2). Moderate-to-severe pain was
present at rest in 55 (21%) patients and during walking in 111 (43%)Fig. 2. Numbers of patients with and without pain during walking before and 1 year
after surgery. The numbers of patients are reported in the histograms and the pro-
portions of patients on the Y-axis.
























































Factors associated with moderate-to-severe pain (M/S pain) at rest 1 year after
orthopaedic surgery on the foot or ankle.
Variables M/S  pain at rest
after 1 year
n = 55
No M/S pain at
rest after 1 year
n = 205
aP value
n (%) n (%)
Female gender 42 (76) 143 (70) 0.4
BMI > 30 kg/m2 7 (13) 40 (21) 0.242
Age < 50 years 18 (33) 41 (20) 0.069
Preoperative use of
analgesics
35 (69) 89 (51) 0.037
Preoperative use of step 2
analgesics
12 (24) 23 (13) 0.123
Preoperative use of a
walking aid
11 (20) 32 (16) 0.541
Preoperative need for help
with footwear
46 (88) 164 (82) 0.839
Corticosteroid therapy 4 (7) 14 (7) 1
Preoperative neuropathy 1 (2) 9 (4) 1
Inﬂammatory joint disease 6 (11) 24 (12) 1
Revision surgery and/or
remote trauma
23 (42) 56 (27) 0.047
Surgery not on hallux
and/or lesser toes
28 (51) 67 (33) 0.018
Preoperative M/S  pain at
rest
20 (37) 96 (48) 0.166
Preoperative M/S  pain
during walking
4 (7) 29 (15) 0.181
General anaesthesiab 47 (89) 151 (74) 0.027
Analgesia via a popliteal
catheter
50 (91) 175 (85) 0.375
Ketoprofen H0–H24 48 (87) 173 (84) 0.676
Ketamine IV pump
H0–H24
27 (50) 76 (37) 0.088
PCA morphine H0–H24 41 (75) 37 (18) 0.251
Highest NRS score D0
8 pm–8 am > 3
18 (33) 37 (19) 0.04
Highest NRS score D1
8 am–8 am > 3
24 (44) 56 (29) 0.032
Postoperative
complications
22  (40) 55 (27) 0.068
CRPS type I 14 (7) 1 (2) 0.206
M/S: moderate-to-severe; BMI: body mass index; H: hour; IV: intravenous; PCA:
patient-controlled analgesia; NRS: numerical rating scale; D: day; CRPS: complex
regional pain syndrome.
a P values associated with Fisher’s exact test. The variables in bold type were
than currently recommended for foot surgery [9]. Most patients
(87%) received regional analgesia [17–20], as recommended
since 20031. Compared to morphine-based analgesia, regional70 F. Remérand et al. / Orthopaedics & Trauma
he preoperative pain scores, the pain scores 1 year postoperatively
ere lower by 2.2 ± 4.2 at rest and by 3.6 ± 3.7 during walking.
.4. Impact of moderate-to-severe chronic postoperative pain
CPOP) at rest and during walking
Moderate-to-severe CPOP at rest was signiﬁcantly associated
ith higher proportions of patients using analgesics (65% vs. 23%,
 < 0.001) and step 2 analgesics (27% vs. 7%, P < 0.001), discomfort
uring everyday activities (85% vs. 35%, P < 0.001), difﬁculties with
ootwear (82% vs. 41%, P < 0.001), and need for a walking aid (22%
s. 8%, P = 0.004).
Moderate-to-severe CPOP during walking was signiﬁcantly
ssociated with the same ﬁve factors: higher proportions of
atients using analgesics (57% vs. 13%, P < 0.001), step 2 analgesics
23% vs. 3%, P < 0.001), discomfort during everyday activities (80%
s. 17%, P < 0.001), difﬁculties with footwear (74% vs. 32%, P < 0.001),
nd need for a walking aid (18% vs. 5%, P < 0.001). In addition,
oderate-to-severe CPOP during walking was signiﬁcantly asso-
iated with neuropathic pain (7% vs. 0%, P = 0.006).
.5. Factors associated with moderate-to-severe chronic
ostoperative pain (CPOP) 1 year after surgery
By univariate analysis, 10 factors were signiﬁcantly associ-
ted with moderate-to-severe CPOP at rest after 1 year (Table 1).
ollinearity was found between preoperative use of analgesics and
reoperative use of step 2 analgesics, as well as between highest
RS pain score > 3 during the ﬁrst postoperative night (8 pm–8 am)
nd highest NRS pain score > 3 during the ﬁrst postoperative day
8 am–8 am); in both cases, only the variable yielding the lowest P
alue was entered into the multivariate model. In the multivariate
odel including the perioperative variables (i.e., excluding post-
perative complications and complex regional pain syndrome type
), the only factor signiﬁcantly associated with moderate-to-severe
POP at rest after 1 year was moderate-to-severe pain (highest NRS
ain score > 3) on the ﬁrst postoperative day (8 am–8 am): odds
atio (OR), 2.0; 95% conﬁdence interval (95%CI), 1.1–3.7; P = 0.043.
By univariate analysis, 12 factors were signiﬁcantly associ-
ted with moderate-to-severe CPOP during walking after 1 year
Table 2). Collinearity was found between the same two pairs of
ariables as for CPOP at rest, and only the variables yielding the
owest P values were entered into the multivariate model (pre-
perative use of analgesics and highest NRS pain score > 3 during
he ﬁrst postoperative night [8 pm–8 am]). By multivariate analy-
is including eight perioperative variables (3, 5, 7, 11, 12, 14, 15,
nd 20 in Table 2), only two variables were signiﬁcantly associated
ith moderate-to-severe CPOP during walking, namely, moderate-
o-severe pain during the ﬁrst postoperative night (OR, 2.6; 95%CI,
.4–4.8; P = 0.048) and revision surgery or surgery after a trauma in
he distant past (OR, 3.7; 95%CI, 2.1–6.3; P = 0.001).
. Discussion
One year after foot surgery, CPOP is common but neuropathic
ain is rare. Several hypotheses can be put forward to explain the
ccurrence of CPOP and to suggest avenues for effective prevention.
n our prospective study, 21% of 260 patients reported CPOP at rest
nd 43% during walking 1 year after foot surgery. These rates of
ccurrence are similar to those reported after surgical procedures
elieved to be more aggressive, such as thoracotomy, mastec-
omy, and arthroplasty [1–3,6,7]. In contrast, the 3% occurrence rate
9/260) of neuropathic CPOP 1 year after surgery is substantially
ower than after more aggressive surgical procedures [4]. This rate
ay  have been underestimated by our deﬁnition of neuropathicentered into the multivariate model.
b With or without regional analgesic via a popliteal perineural catheter.
pain based only on the ﬁrst two questions in the DN4 score, with-
out questions 3 and 4, which require physical examination of the
patient [16]. However, the two-question self-report version and
the full four-question version have demonstrated closely similar
sensitivity (78% vs. 83%) [16].
In contrast to most studies of CPOP, our study involved a detailed
description of the intra-operative and postoperative analgesia
modalities. Inadequate analgesia would be expected to increase the
rate of occurrence of CPOP after 1 year. However, the multimodal
analgesic regimen used in our patients was slightly more intensive1 Recommendations issued by the French Society for Anaesthesia and Inten-
sive Care (SFAR): http://www.sfar.org/article/155/les-blocs-peripheriques-des-
membres-chez-l-rsquo-adulte, last accessed on 6 June, 2013.
F. Remérand et al. / Orthopaedics & Traumatology
Table  2
Factors associated with moderate-to-severe pain (M/S pain) during walking 1 year
after orthopaedic surgery on the foot or ankle.









n (%) n (%)
Female gender 78 (70) 107 (72) 0.78
BMI  > 30 kg/m2 16 (15) 31 (22) 0.193
Age < 50 years 32 (29) 27 (18) 0.053
Corticosteroid therapy 5 (5) 13 (9) 0.223
Preoperative use of
analgesics
62 (63) 62 (49) 0.042
Preoperative use of step 2
analgesics
21 (22) 14 (11) 0.041
Preoperative use of a
walking aid
26 (24) 17 (12) 0.011
Preoperative need for help
with footwear
86 (81) 122 (84) 0.636
Neuropathy 4 (4) 6 (4) 0.952
Inﬂammatory disease 13 (12) 17 (11) 1
Revision surgery and/or
remote trauma
51 (46) 28 (19) < 0.001
Surgery not on hallux
and/or lesser toes
49 (44) 46 (31) 0.037
Preoperative M/S pain at
rest
46 (43) 70 (48) 0.523
Preoperative M/S  pain
during walking
7 (7) 26 (18) 0.008
General anaesthesiab 91 (83) 107 (72) 0.036
Analgesia via a popliteal
catheter
98 (88) 127 (85) 0.582
Ketoprofen H0–H24 92 (83) 20 (13) 0.483
Ketamine IV pump H0–H24 46 (42) 57 (38) 0.608
PCA morphine H0–H24 26 (23) 25 (17) 0.208
Highest NRS score D0
8 pm–8 am > 3
34 (31) 21 (15) 0.002
Highest NRS score D1
8 am–8 am > 3
44 (41) 36 (25) 0.014
Postoperative
complications
45  (41) 32 (21) 0.001
CRPS type I 13 (9) 2 (2) 0.028
M/S: moderate-to-severe; BMI: body mass index; H: hour; IV: intravenous; PCA:
patient-controlled analgesia; NRS: numerical rating scale; D: day; CRPS: complex
regional pain syndrome.


















standard of care. This rate was  not inﬂuenced by the site of surgeryntered into the multivariate model.
b With or without regional analgesic via a popliteal perineural catheter.
nalgesia improves pain relief [21,22] and allows earlier rehabilita-
ion therapy [23]. The proportion of patients who  received regional
nalgesia in our study was substantially higher than in a nationwide
tudy conducted in France [24]. The systemic multimodal anal-
esia regimen comprised ketoprofen and paracetamol, often with
etamine. At present, ketamine is recommended only after more
ggressive surgical procedures [25]. Despite our intense analgesic
egimen, 19% to 44% of patients experienced moderate-to-severe
ain within 48 hours after surgery (Tables 1 and 2), suggesting a
eed for increased attention to implementation of the multimodal
nalgesia regimen.
Several lines of evidence suggest that pain after orthopaedic foot
urgery may  differ from typical CPOP [1]. The very high frequency
f postoperative pain in our study (65% at rest and 93% during
alking), intensive multimodal analgesia regimen, and very low
requency of postoperative neuropathic pain (3%) do not support a
ausal link between the surgical procedure and the pain reported: Surgery & Research 100 (2014) 767–773 771
1 year later. In most patients, persistence of the preoperative pain is
a more likely hypothesis. A high frequency of persistent pain may
indicate that surgery was performed at an excessively advanced
stage of the disease process [26].
Complex regional pain syndrome type I and surgical complica-
tions were not entered into our multivariate model. We  chose to
focus on variables accessible to clinicians during the perioperative
period, that is, assessable before or within 48 hours after the sur-
gical procedure. By multivariate analysis, only two  such variables
were signiﬁcantly associated with CPOP. One of these variables
was moderate-to-severe pain within 48 hours after surgery. Acute
postoperative pain is a well-established risk factor for CPOP [1].
Importantly, in our study, the time of occurrence of moderate-to-
severe pain (ﬁrst postoperative night vs. ﬁrst postoperative day,
Tables 1 and 2) had little inﬂuence on the association with CPOP
after 1 year. This ﬁnding suggests that the analgesic regimen should
be administered for a sufﬁciently long period after surgery and not
only during the ﬁrst few hours. The other variable was prior surgery
or trauma of the foot. Taken alone, this ﬁnding might suggest a
role for sensitisation to pain during the initial insult. However, the
low frequency of neuropathic pain makes this explanation unlikely.
A more plausible hypothesis is that prior surgery or trauma is
a marker for greater severity of the bone and joint lesions, par-
ticularly when previous surgery was required. This hypothesis is
consistent with the possibility that surgery was performed at an
excessively advanced stage of lesion progression.
An interesting ﬁnding from our study is that ketamine adminis-
tration within the ﬁrst 24 hours after surgery was not associated
with a decreased frequency of moderate-to-severe CPOP after
1 year. This ﬁnding is unexpected, since ketamine has been proven
effective in relieving acute and chronic pain after total hip arthro-
plasty [9]. In our study, two  reasons preclude deﬁnitive conclusions
regarding the absence of a beneﬁcial effect of ketamine in reliev-
ing pain. First, ketamine therapy was probably reserved for those
patients considered at high risk for acute and chronic postoperative
pain. Second, a ketamine bolus is administered almost routinely at
anaesthesia induction in our department, whereas only the admin-
istration of ketamine as a continuous infusion was recorded for our
study.
Another negative ﬁnding from our study deserves to be high-
lighted: the frequency of CPOP after 1 year was not lower in the
subgroup of patients whose surgical procedure was conﬁned to the
hallux or lesser toes. Proximal foot surgery, deﬁned as surgery at
sites located between the Lisfranc joint and the ankle, is gener-
ally held to be more complex and motivated by more advanced
stages of deformities or disease processes (inﬂammatory disease,
post-traumatic osteoarthritis) [26,27] compared to surgery on the
hallux or lesser toes. Until future studies of this point become avail-
able, our ﬁndings suggest a similar risk of CPOP after 1 year in all
patients undergoing foot surgery (other than surgery on a single
lesser toe). Therefore, the same analgesic regimen should be used
in all these patients. This approach raises challenges with adapting
the analgesic regimen to outpatient care (most notably, continuous
ketamine therapy).
5. Conclusion
One year after foot surgery, the rate of occurrence of moderate-
to-severe CPOP was similar to that seen after more aggressive
procedures, despite an analgesic regimen complying with the best(ankle, hindfoot, or hallux/lesser toes). Neuropathic pain was very
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ppendix 1. Questionnaire used for the telephone
nterview 1 year after orthopaedic surgery on the foot
1. Can you score your pain at rest in the operated foot?
0 = no pain at all
10 = worst possible pain
score: . . ..  . ..  . ..  . ..  . ........... /10
2. Can you say where your pain at rest is located in the oper-
ted foot?
ankle, heel, sole, top of the foot, inside of the foot, outside of the
oot, big toe (ﬁrst ray), second toe/ray, third toe/ray, fourth toe/ray,
fth toe/ray
3. Can you score your pain during walking in the operated
oot?
0 = no pain at all
10 = worst possible pain
score: . . ..  . ..  . ..  . ..  . .......  . .... /10
4. Can you say where your pain during walking is located in
he operated foot?
ankle, heel, sole, top of the foot, inside of the foot, outside of the
oot, big toe (ﬁrst ray), second toe/ray, third toe/ray, fourth toe/ray,
fth toe/ray
5. Does your pain have any of the features listed below?
burning, painful cold, electric shocks
6. Is the pain associated with one or more of the following
ymptoms in the same area?
tingling, pins and needles, numbness, itching
7. Does your pain interfere with your everyday life?
no, somewhat, to a large extent
8. What analgesics do you take for your foot pain and, on
verage, how much do you take each day?
Yes No
Specify the amount per day
 paracetamol . . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..... . ..
 dextropropoxyphene + paracetamol
 . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..  . .....
 paracetamol + codeine . . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..  . .....
 tramadol or similar . . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..... . ..
 NSAID: name.........  . .......... . . ..  . ..  . ..  . ..  . ..  . ..  . ..... . ..  . ..  . ..
 other: name........ . ............ . . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..... . ..
 other: name.........  . ........... . . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..... . ..
9. To walk, do you use
no aid, help from another person, one crutch, two crutches, a
alker; or are you unable to walk (conﬁned to an armchair)
10. Do you have difﬁculty putting on your shoe on the oper-
ted side?
no difﬁculty, some difﬁculty (but ‘normal’ footwear), major dif-
culties (custom-made footwear)
11. Did you experience any complications after the opera-
ion?
infection, wound dehiscence, haematoma, complex regional
ain syndrome, other: please specify
12. Did you experience any complications after the anaesthe-ia? (please specify)
prolonged anaesthesia, prolonged paralysis, painful sequelae,
ther: please specify
13. Do you remember the pain you had before the operation?: Surgery & Research 100 (2014) 767–773
yes, no
IF YES
14. Can you score your pain at rest in the operated foot?
0 = no pain at all
10 = worst possible pain
score: . . ..  . ..  . ..  . ..  . ..  . ......... /10
15. Can you say where your pain at rest was  located in the
operated foot?
ankle, heel, sole, top of the foot, inside of the foot, outside of the
foot, big toe (ﬁrst ray), second toe/ray, third toe/ray, fourth toe/ray,
ﬁfth toe/ray
16. Can you score your pain during walking in the operated
foot?
0 = no pain at all
10 = worst possible pain
score: . . ..  . ..  . ..  . ..  . ... . ....... /10
17. Can you say where your pain during walking was  located
in the operated foot?
ankle, heel, sole, top of the foot, inside of the foot, outside of the
foot, big toe (ﬁrst ray), second toe/ray, third toe/ray, fourth toe/ray,
ﬁfth toe/ray
18. Did your pain have any of the features listed below?
burning, painful cold, electric shocks
19. Was  the pain associated with one or more of the following
symptoms in the same area?
tingling, pins and needles, numbness, itching
20. What analgesics did you take for your foot pain and, on
average, how much did you take each day?
Yes No
Specify the amount per day
 paracetamol . . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..... . ..  . ..
 dextropropoxyphene + paracetamol
. . ..  . ..... . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..
 paracetamol + codeine . . ..  . ..  . ..  . ..  . ..  . ..  . ..... . .. . ..  . ..
 tramadol or similar . . ..  . ..  . ..  . ..  . ..  . ..  . ..  . ..... . ..  . ..
 NSAID: name.........  . .......... . . ..  . ..  . .. . ..... . ..  . ..  . ..  . ..  . ..  . ..
 other: name............ . ........ . . ..  . ..  . ..  . ..... . ..  . ..  . .. . ..  . ..  . ..
 other: name............ . ........ . . ..  . ..... . ..  . ..  . ..  . ..  . .. . ..  . ..  . ..
21. To walk, did you use
no aid, help from another person, one crutch, two crutches, a
walker; or were you unable to walk (conﬁned to an armchair)
22. Did you have difﬁculty putting on your shoe on the side
where you subsequently had the operation?
no difﬁculty, some difﬁculty (but ‘normal’ footwear), major dif-
ﬁculties (custom-made footwear)
23. When did you have pain in the foot on the side where you
subsequently had the operation?
At rest: . . ..  . ..  . .............. during walking: . . ..  . ..  . .............
Appendix 2. Determination of the DN2 score (or seven-item
DN4 score)
The DN2 score is based on the responses to the following two
questions.
1. Does the pain have one or more of the following charac-
teristics?
burning, painful cold, electric shocks
2. Is the pain associated with one or more of the following
symptoms in the same area?
tingling, pins and needles, numbness, itching
The DN2 score is the number of symptoms present among the
seven above-listed symptoms. Neuropathic pain is deﬁned as a DN2
score equal to or greater than 3, i.e., as the presence of at least three
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